Andina Acquisition Corp. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Spanish EU GMP Facility now has licences to cultivate, extract and manufacture cannabis extract  EMMAC now licensed to cultivate medical cannabis in Portugal and Spain  LONDON, July 28, 2020 (GLOBE NEWSWIRE) -- EMMAC Life Sciences Group, Europe’s largest independent cannabis company, is pleased to announce that Medalchemy, the Group’s Good Manufacturing Practice (“GMP”) certified manufacturing site in Alicante, Spain has secured approval from the Spanish Health Authorities (“AEMPS”) to cultivate medical cannabis. Medalchemy now has fully integrated cannabis supply facilities, with a licence to grow medical cannabis commercially as well as extract and manufacture cannabis extract as an active pharmaceutical ingredient (“API”)...

EMMAC Executive Chairman Lorne Abony By Jarrett Banks EMMAC Life Sciences, Europe’s largest cannabis company, will go public through a merger with Andina Acquistion Corp. III, giving U.S. investors access to the white-hot medical cannabis sector in Europe. EMMAC signed a letter of intent to combine with the special purpose acquisition company, or SPAC, to […]

EMMAC Life Sciences, one of Europe's largest cannabis companies, announced its plans to go public in the U.S.It will list on the Nasdaq exchange through a merger with Andina Acquisition Corp. III (NASDAQ: ANDA) (NASDAQ: ANDAW) (NASDAQ: ANDAU). EMMAC shareholders expect to collectively own a majority stake in the combined public company. EMMAC's Chairman Lorne Abony, CEO Antonio Costanzo, CFO Thomas Ellen, and COO Tom Rooke, will continue to lead the combined entity.Commenting on the news, Luke Weil, Chairman of Andina, told Benzinga that EMMAC is an "extremely attractive investment opportunity due to its leadership position in the large European market, which is driving strong revenue growth with a clear path to profitability...

Andina Acquisition Corp. III is a LATAM focused SPAC that will hold a special shareholders meeting on July 29, 2020 to extend its liquidation deadline by three months to October.

Embotelladora Andina SA ADR Series A (NYSE:AKO.A) will be announcing its earnings results after the market closes on Tuesday, April 28th. Investors interested in listening to the company’s conference call can do so using this link. Embotelladora Andina SA ADR Series A (NYSE:AKO.A) last released its quarterly earnings results on Tuesday, February 25th. The company […]

Embotelladora Andina SA ADR Series A (NYSE:AKO.A) shares crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $13.79 and traded as low as $10.41. Embotelladora Andina SA ADR Series A shares last traded at $10.50, with a volume of 6,700 shares. […]

Embotelladora Andina SA ADR Series A (NYSE:AKO.A)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $14.02 and traded as low as $10.96. Embotelladora Andina SA ADR Series A shares last traded at $10.96, with a volume of 1,100 shares changing hands. Separately, […]

Q3 2019 Arca Continental SAB de CV Earnings Call

Andina Acquisition Corp. III (NASDAQ:AMCI) and Global Cord Blood (NYSE:CO) are both small-cap unclassified companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings. Profitability This table compares Andina Acquisition Corp. III and Global Cord Blood’s […]